Cargando…
Safety and Efficacy of the 10-Day Melarsoprol Schedule for the Treatment of Second Stage Rhodesiense Sleeping Sickness
OBJECTIVE: Assessment of the safety and efficacy of a 10-day melarsoprol schedule in second stage T.b. rhodesiense patients and the effect of suramin-pretreatment on the incidence of encephalopathic syndrome (ES) during melarsoprol therapy. DESIGN: Sequential conduct of a proof-of-concept trial (n =...
Autores principales: | Kuepfer, Irene, Schmid, Caecilia, Allan, Mpairwe, Edielu, Andrew, Haary, Emma P., Kakembo, Abbas, Kibona, Stafford, Blum, Johannes, Burri, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435133/ https://www.ncbi.nlm.nih.gov/pubmed/22970329 http://dx.doi.org/10.1371/journal.pntd.0001695 |
Ejemplares similares
-
Clinical Presentation of T.b. rhodesiense Sleeping Sickness in Second Stage Patients from Tanzania and Uganda
por: Kuepfer, Irene, et al.
Publicado: (2011) -
Trypanososma brucei rhodesiense Sleeping Sickness, Uganda
por: Berrang-Ford, Lea, et al.
Publicado: (2012) -
Quantifying the Burden of Rhodesiense Sleeping Sickness in Urambo District, Tanzania
por: Matemba, Lucas E., et al.
Publicado: (2010) -
High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo
por: Robays, Jo, et al.
Publicado: (2008) -
Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association
por: Seixas, Jorge, et al.
Publicado: (2020)